Novartis Bets On Buybacks Due To Limited M&A Options

Unveils Another $15bn Share Repurchasing Program

 
• By Kevin Grogan
  
Harry Kirsch
CFO Harry Kirsch • Source: Novartis
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business